Imreg 1
Latest Information Update: 29 Nov 2000
At a glance
- Originator Imreg
- Class Antineoplastics
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 29 Nov 2000 No-Development-Reported for HIV-1 infections in USA (Intradermal)